SR-B1, a Key Receptor Involved in the Progression of Cardiovascular Disease: A Perspective from Mice and Human Genetic Studies
High plasma level of low-density lipoprotein (LDL) is the main driver of the initiation and progression of cardiovascular disease (CVD). Nevertheless, high-density lipoprotein (HDL) is considered an anti-atherogenic lipoprotein due to its role in reverse cholesterol transport and its ability to rece...
Main Authors: | Gracia-Rubio Irene, Martín César, Civeira Fernando, Cenarro Ana |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/9/6/612 |
Similar Items
-
Physiological importance of SR-BI in the in vivo metabolism of human HDL and LDL in male and female mice
by: Mathieu R. Brodeur, et al.
Published: (2005-04-01) -
The hepatic uptake of VLDL in lrp−ldlr−/−vldlr−/− mice is regulated by LPL activity and involves proteoglycans and SR-BI
by: Lihui Hu, et al.
Published: (2008-07-01) -
Absence of HDL cholesteryl ester uptake in mice via SR-BI impairs an adequate adrenal glucocorticoid-mediated stress response to fasting
by: Menno Hoekstra, et al.
Published: (2008-04-01) -
A quantitative analysis of apolipoprotein binding to SR-BI: multiple binding sites for lipid-free and lipid-associated apolipoproteins
by: Stephen T. Thuahnai, et al.
Published: (2003-06-01) -
C323 of SR-BI is required for SR-BI-mediated HDL binding and cholesteryl ester uptake[S]
by: Ling Guo, et al.
Published: (2011-12-01)